ArtsAutosBooksBusinessEducationEntertainmentFamilyFashionFoodGamesGenderHealthHolidaysHomeHubPagesPersonal FinancePetsPoliticsReligionSportsTechnologyTravel

Targeted siRNA Silences Cancer Cells

Updated on August 3, 2010

Mark E. Davis, PhD

Another Cancer Treatment - Silencing RNA

Mark E. Davis, professor at California Institute of Technology, has been working on a new cancer treatment for specific types of malignancies. The treatment delivers what are called silencing RNA (siRNA) sequences to specific genes implicated in cancer growth and creation. This therapy, because it is still so new, can also be called RNA interference or RNAi.

Dr. Davis is no stranger to this branch of science. See my hub on "How Nanotechnology has been applied to cancer treatment." In that attempt, which is still undergoing clinical trials, Dr. Davis encapsulated a cancer toxin in a nano-particle consisting of a sugary starch called Cyclodextrin which is non-toxic and does not cause an immune response. Buried within the cyclodextrin is a toxic molecule called Camptothecin. Because cancer cells are "ravenous", delivering a toxin in a sugary coating to them this way appears to be quite effective. Again, trials are ongoing.

Dr. Davis' newest field of research is both preventative and curative in nature. This latest foray into oncological* science uses nanotechnology to deliver silencing RNA to DNA strands which may be capable of expressing (malignancies) cancers.

Cyclodextrin is still being used and since siRNA is non-toxic this new technique promises to be much easier on the patient that current chemo-therapies.

Self Organizing "Smart" Bombs

The current research in this area is self-formation of cyclodextrin molecules (again because they are non toxic, do not illicit an immune response, and are self organizing) in a variety of formations. Researchers have found that cyclodextrin nano-particles with specific size and geometric formation tend to "flock toward" specific areas of the body. The net effect is to tailor the nano-particle to a particular biological area such as the prostate, pancreas, or skin. This in turn will give a much finer degree of control over how the particles work, what they target, and how effectively they deliver the "payload." Payload in this case being a toxin strong enough to destroy cells...cancer cells.

Another "upside" to this delivery method is that it does not rely on (potentially mutating) viruses as a delivery vehicle and since siRNA is non-toxic typical side-effects of traditional chemo-therapy could be a thing of the past.

Targeting and Cell Uptake

To date all active delivery of these siRNA "bombs" have been preformed on mice. Because the nano-particles have been tailored as to size and shape they tend to deliver themselves to the appropriate places despite having been injected systemically*. Thus the reference to biological function above.

Another issue with this method is uptake. e.g. the ability of the drug, siRNA, or toxin to pass through the cell membrane of the offending cell. If uptake is inhibited the nano-particle may get to it's target, but the payload will never make it's way into the "offending" cell.This problem has also been successfully addressed (to date) with the formation of the self-organizing sugar molecules. Most cells, healthy or otherwise, run on sugars.

Another issue that had to be addressed was the very short "half-life" of siRNA moving freeling in a living body. Typically, siRNA have a very short life (seconds to minutes) and are also readily processed by the kidneys and expelled from the body. By encapsulating these agents within customized nano-particles the half-life of these agents is greatly expanded. They also bypass the renal system (kidneys) due to their size.

Of course all of this is necessary if the agents are to be injected into the body where all manner of organs and cells are designed to destroy "invaders."


* Systemic meaning that the drug is everywhere within the body...the system.

Cancers Targeted

To date studies indicate that this delivery system works effectively in reducing or destroying prostate, pancreatic, and skin (melanoma) cancers in mice. Because these specific types of cells are targeted by the shape of the nano-particle, systemic (body wide) reactions are greatly reduced or even eliminated. And because the delivered "drug" is siRNA the risk of toxic side-effects if further reduced.

Comments

Submit a Comment

  • LiamBean profile imageAUTHOR

    LiamBean 

    9 years ago from Los Angeles, Calilfornia

    WildWade: Thanks for the comment.

    It's really not a surprise you've not heard of this. It isn't even in human trials yet, much less approved by the FDA. I know of Mark E. Davis' work and set about to see what else he might be doing. This is what I found.

    I think it's very promising, but as I said, right now this "therapy" is in animal, not human, trials.

  • wildwade profile image

    wildwade 

    9 years ago from North Olmsted, Ohio

    Very informative article! I had not heard of this as an option. Thanks for the info!

working

This website uses cookies

As a user in the EEA, your approval is needed on a few things. To provide a better website experience, hubpages.com uses cookies (and other similar technologies) and may collect, process, and share personal data. Please choose which areas of our service you consent to our doing so.

For more information on managing or withdrawing consents and how we handle data, visit our Privacy Policy at: https://hubpages.com/privacy-policy#gdpr

Show Details
Necessary
HubPages Device IDThis is used to identify particular browsers or devices when the access the service, and is used for security reasons.
LoginThis is necessary to sign in to the HubPages Service.
Google RecaptchaThis is used to prevent bots and spam. (Privacy Policy)
AkismetThis is used to detect comment spam. (Privacy Policy)
HubPages Google AnalyticsThis is used to provide data on traffic to our website, all personally identifyable data is anonymized. (Privacy Policy)
HubPages Traffic PixelThis is used to collect data on traffic to articles and other pages on our site. Unless you are signed in to a HubPages account, all personally identifiable information is anonymized.
Amazon Web ServicesThis is a cloud services platform that we used to host our service. (Privacy Policy)
CloudflareThis is a cloud CDN service that we use to efficiently deliver files required for our service to operate such as javascript, cascading style sheets, images, and videos. (Privacy Policy)
Google Hosted LibrariesJavascript software libraries such as jQuery are loaded at endpoints on the googleapis.com or gstatic.com domains, for performance and efficiency reasons. (Privacy Policy)
Features
Google Custom SearchThis is feature allows you to search the site. (Privacy Policy)
Google MapsSome articles have Google Maps embedded in them. (Privacy Policy)
Google ChartsThis is used to display charts and graphs on articles and the author center. (Privacy Policy)
Google AdSense Host APIThis service allows you to sign up for or associate a Google AdSense account with HubPages, so that you can earn money from ads on your articles. No data is shared unless you engage with this feature. (Privacy Policy)
Google YouTubeSome articles have YouTube videos embedded in them. (Privacy Policy)
VimeoSome articles have Vimeo videos embedded in them. (Privacy Policy)
PaypalThis is used for a registered author who enrolls in the HubPages Earnings program and requests to be paid via PayPal. No data is shared with Paypal unless you engage with this feature. (Privacy Policy)
Facebook LoginYou can use this to streamline signing up for, or signing in to your Hubpages account. No data is shared with Facebook unless you engage with this feature. (Privacy Policy)
MavenThis supports the Maven widget and search functionality. (Privacy Policy)
Marketing
Google AdSenseThis is an ad network. (Privacy Policy)
Google DoubleClickGoogle provides ad serving technology and runs an ad network. (Privacy Policy)
Index ExchangeThis is an ad network. (Privacy Policy)
SovrnThis is an ad network. (Privacy Policy)
Facebook AdsThis is an ad network. (Privacy Policy)
Amazon Unified Ad MarketplaceThis is an ad network. (Privacy Policy)
AppNexusThis is an ad network. (Privacy Policy)
OpenxThis is an ad network. (Privacy Policy)
Rubicon ProjectThis is an ad network. (Privacy Policy)
TripleLiftThis is an ad network. (Privacy Policy)
Say MediaWe partner with Say Media to deliver ad campaigns on our sites. (Privacy Policy)
Remarketing PixelsWe may use remarketing pixels from advertising networks such as Google AdWords, Bing Ads, and Facebook in order to advertise the HubPages Service to people that have visited our sites.
Conversion Tracking PixelsWe may use conversion tracking pixels from advertising networks such as Google AdWords, Bing Ads, and Facebook in order to identify when an advertisement has successfully resulted in the desired action, such as signing up for the HubPages Service or publishing an article on the HubPages Service.
Statistics
Author Google AnalyticsThis is used to provide traffic data and reports to the authors of articles on the HubPages Service. (Privacy Policy)
ComscoreComScore is a media measurement and analytics company providing marketing data and analytics to enterprises, media and advertising agencies, and publishers. Non-consent will result in ComScore only processing obfuscated personal data. (Privacy Policy)
Amazon Tracking PixelSome articles display amazon products as part of the Amazon Affiliate program, this pixel provides traffic statistics for those products (Privacy Policy)